Christina Vleisides

Tositumomab and I 131 Tositumomab Achieves Complete Remissions Lasting > 10 Years In Patients with Chemotherapy-Refractory Low-Grade and Transformed B-Cell Lymphomas

J. Vose, A. Zelenetz, M. Kaminski, 2010 .